XERACALM AD
Lipid-replenishing cream
XERACALM AD relipidant cream has been specially formulated to meet the needs of very dry skin with an atopic tendency.
This high-tolerance skin care product rebalances the microbiome and restores the skin barrier, thanks to a new combo of cutting-edge active ingredients:
- I-MODULIA⁺, an optimized version of our patented anti-itching active, targets the virulence factors of Staphylococcus aureus at the heart of the skin microbiome.
- The patented LIPID:B2 complex, highly concentrated in fatty acids. It contributes to and stimulates the synthesis of ceramides, essential components in the skin's barrier to aggression.
Two alternative textures are available, offering the same triple efficacy:
IMMEDIATE SOOTHING - ANTI-DEMANGE - ANTI-RECHUGE: Balm and Milky Gel
Fragrance-free, non-comedogenic and sterile-packed, XERACALM AD cream guarantees efficacy, safety and maximum tolerance, even on the most sensitive skin or skin weakened by specific oncological / dermatological treatments.
- Legal information
-
*Clinical study, 2 applications per day for 3 months, 55 subjects, limits the risk of recurrence of intense dryness flare-ups.
-
For whom?From birthFamily
-
Price200ml19,50€400ml25,90€
-
TextureFragrance-free, non-greasy, non-sticky
Patient relations
-
Application tips
Apply 1-2 times a day to dry areas of the face and/or body.
For a gentle application, first spread the cream in your hands, then spread it over the entire body with the entire surface of your hands, using broad strokes. To avoid irritating the skin, avoid rubbing.
-
In combination with the following treatments
Tolerance tested in association with atopic dermatitis and oncology treatments.
I-MODULIA+ acts specifically on the virulence of S.AUREUS
Staphylococcus aureus is an opportunistic pathogen that can be part of the skin microbiome as a commensal. Under certain conditions, it can adopt virulent behavior and secrete virulence factors capable of disrupting epidermal integrity, activating the immune system and exacerbating cutaneous inflammation.
I-MODULIA+ acts directly on the main virulence factors produced by Staphylococcus aureus, helping to reduce its inflammatory potential. By targeting these molecular triggers, it promotes the bacterium's return to a commensal state, where it coexists harmlessly with the skin microbiome.
Ingredients
Active ingredients:
I-MODULIA+ embodies the evolution of our multi-competent postbiotic active ingredient.
The most effective nutrient complex identified in over 20,000 models1. Provides the lipids essential to the proper functioning of the skin barrier and reinforces it.
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Tolerance results
Excellent skin and eye tolerance
Efficacy results
Instant soothing** | Anti-itching** | Anti-replication***
in 1 week*
in 1 week*
Terms of use
**Linked to skin dryness
***Helps reduce the risk of recurrence of severe dryness.
*Clinical evaluation, twice-daily application for 3 months, 55 subjects, reduced the risk of recurrence of severe dryness.
*Clinical evaluation, twice-daily application for 3 months, 55 subjects, reduced the risk of recurrence of severe dryness.
Discover the range
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.